Treat juvenile idiopathic arthritis according to disease subtype and severity

Abstract

Juvenile idiopathic arthritis (JIA) is a leading cause of short- and long-term disability in children. Treatment options include NSAIDs, intra-articular and systemic corticosteroids, and conventional and biological disease-modifying antirheumatic drugs. The optimal pharmacological treatment approach depends on JIA subtype and disease severity, with physical and occupational therapy and psychosocial support also being important.

http://ift.tt/2pdJEIR